# Exercise and Pharmacotherapy for Anxiety in Cardiac Patients

> **NCT02516332** · NA · COMPLETED · sponsor: **Duke University** · enrollment: 128 (actual)

## Conditions studied

- Anxiety
- Cardiovascular Disease

## Interventions

- **DRUG:** Lexapro
- **DRUG:** Placebo
- **BEHAVIORAL:** Supervised Aerobic Exercise

## Key facts

- **NCT ID:** NCT02516332
- **Lead sponsor:** Duke University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-12
- **Primary completion:** 2020-05-01
- **Final completion:** 2021-05
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2021-06-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02516332

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02516332, "Exercise and Pharmacotherapy for Anxiety in Cardiac Patients". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02516332. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*